When should benzodiazepines (BZDs) be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Appropriate Indications for Benzodiazepine Use

Benzodiazepines should be used only for specific short-term indications with clear therapeutic goals, and should generally be avoided for long-term use due to risks of dependence, tolerance, and adverse effects. 1

Primary Indications for Benzodiazepine Use

  • Alcohol Withdrawal Syndrome (AWS): Benzodiazepines are the first-line treatment for AWS, with long-acting benzodiazepines (chlordiazepoxide, diazepam) recommended for seizure prevention in most patients, and intermediate-acting benzodiazepines (lorazepam) recommended for patients with severe AWS, advanced age, liver failure, or serious medical comorbidities 1

  • Alcohol or Benzodiazepine Withdrawal: Benzodiazepines are the treatment of choice as monotherapy for these specific withdrawal syndromes 1

  • Acute Severe Agitation with Risk of Harm: May be used as crisis medication in the management of delirious patients with severe agitation and distress when the patient poses a risk to themselves or others, but only after behavioral interventions have failed 1

  • Short-term Insomnia: Limited to transient or short-term insomnia, with prescriptions ideally limited to a few days, occasional use, or courses not exceeding 2-4 weeks 1, 2

  • Acute Anxiety States: For acute stress reactions, episodic anxiety, or as initial treatment for severe panic, given in single doses or very short courses (1-7 days) 2

Important Limitations and Precautions

  • Duration of Treatment:

    • For insomnia: Limit to 2-4 weeks maximum 1, 2, 3
    • For anxiety: Short courses (2-4 weeks) and only rarely for longer-term treatment 2
  • Avoid in Older Adults: High-potency, long-acting, or prolonged use of benzodiazepines are considered high-risk in older patients due to increased risk of falls, cognitive impairment, and reduced mobility 1

  • Contraindications:

    • Severe pulmonary insufficiency
    • Severe liver disease
    • Myasthenia gravis
    • Patients with history of substance abuse 1, 4

Risks and Adverse Effects

  • Dependence and Withdrawal: Physical dependence can develop even after relatively short-term use (2-4 weeks) 5, 4, 3

  • Withdrawal Symptoms: Include seizures, anxiety, insomnia, sensory hypersensitivity, paresthesias, muscle cramps, diarrhea, blurred vision, and in severe cases, delirium tremens 5, 4

  • Cognitive Effects: Memory disruption, psychomotor impairment, increased risk of accidents 3, 6

  • Paradoxical Reactions: Can cause increased agitation, hostility, and anxiety in some patients 3, 6

  • Falls and Injuries: Particularly concerning in older adults 1

Specific Recommendations for Different Clinical Scenarios

  • For Alcohol Withdrawal:

    • First-line treatment with psychiatric consultation recommended 1
    • Long-acting benzodiazepines (chlordiazepoxide, diazepam) for most patients
    • Lorazepam for patients with liver failure, respiratory failure, advanced age, or serious comorbidities 1
  • For Delirium with Agitation:

    • Use only after non-pharmacological approaches have failed
    • Use the lowest effective dose for the shortest possible time
    • Midazolam 2.5 mg SC/IV or lorazepam 1 mg SC/IV as needed, with lower doses in elderly or frail patients 1
  • For Insomnia:

    • Should be supplemented with behavioral and cognitive therapies
    • Short-intermediate acting agents preferred (temazepam, loprazolam, lormetazepam)
    • Avoid potent, short-acting benzodiazepines like triazolam which carry greater risks 1, 2

Alternatives to Consider Before Using Benzodiazepines

  • For Anxiety: Psychological treatments, antidepressants, and other non-benzodiazepine medications should be considered first-line 2, 3

  • For Insomnia: Cognitive behavioral therapy for insomnia (CBT-I), stimulus control therapy, relaxation therapy, and sleep restriction are recommended as initial interventions 1

  • For Older Adults: Consider psychological or alternative pharmacological treatments including antidepressants, cognitive-behavioral therapy, or integrative strategies 1

Key Points for Safe Prescribing

  • Use the lowest effective dose for the shortest duration possible 7
  • Regularly reassess the need for continued treatment 1
  • Taper gradually when discontinuing to minimize withdrawal symptoms 4
  • Be aware that benzodiazepines can themselves cause delirium and increased agitation 1
  • Avoid combining with other CNS depressants, especially opioids 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.